LSN Life Sciences Institute Inc.

Life Sciences Institute Inc. (TSX VENTURE:LSN) ("LSN" or the "Corporation") is
pleased to announce that it has amended and filed a Short Form Offering Document
("SFOD") and entered into an amended agency agreement with Wolverton Securities
Ltd. ("Wolverton") in connection with its previously announced SFOD financing
(the "SFOD Offering"). The SFOD Offering will consist of up to a maximum of
$2,000,000 in units of the Corporation. Units are being offered at $0.05 per
unit (each, a "Unit") and each Unit will be comprised of: (i) one common share
in the capital of the Corporation ("Common Share"); and (ii) one
non-transferable Common Share purchase warrant (a "Warrant"). Each Warrant will
entitle the holder thereof to purchase one Common Share for a period of
twenty-four (24) months from the closing date at an exercise price of $0.10 per
Common Share with an accelerated expiry date, subject to notice from the
Corporation, of thirty (30) days from the date such notice is provided, if the
Common Shares trade and if the closing price of the Common Shares on the TSXV
for any fifteen (15) consecutive trading days is equal or above $0.15 per Common
Share.


Wolverton will receive a commission equal to 8.0% of the gross proceeds received
by the Corporation from sales pursuant to the SFOD Offering. Wolverton will also
receive an option to acquire up to that number of units ("Agent's Units") that
is equal to 8.0% of the aggregate number of Units sold pursuant to the SFOD
Offering, at price of $0.05 per Agent's Unit for a period of 36 months from the
date of issue. Each Agent's Unit will consist of one (1) Common Share and one
(1) Warrant.


The net proceeds to be received by the Corporation from the SFOD Offering will
be used by the Corporation primarily for the purposes of completing drilling
programs, completing a 3D seismic program and general working capital purposes.


The filing of the Short Form Offering Document with the TSX Venture Exchange
(the "TSXV") will occur immediately after the issuance of this press release.
Once the TSXV has issued an Exchange Bulletin indicating acceptance of the SFOD,
the SFOD Offering must be closed within thirty (30) days.


Forward Looking Statements

Statements in this press release contain forward-looking information within the
meaning of applicable securities law. Forward-looking information is frequently
characterized by words such as "plan", "expect", "project", "intend", "believe",
"anticipate", "estimate" and other similar words, or statements that certain
events or conditions "may" or "will" occur. In particular, forward-looking
information in this press release includes, without limitation, statements with
respect to: timing and completion of the SFOD Offering and the approval of the
TSX Venture Exchange. Readers are cautioned that assumptions used in the
preparation of forward-looking information may prove to be incorrect. Although
we believe that the expectations reflected in the forward-looking information
are reasonable, there can be no assurance that such expectations will prove to
be correct. We cannot guarantee future results, level of activity, performance
or achievements. Consequently, there is no representation that the actual
results achieved will be the same, in whole or in part, as those set out in the
forward-looking information.


Forward-looking information is based on the opinions and estimates of management
at the date the statements are made, and are subject to a variety of risks and
uncertainties and other factors (many of which are beyond the control of the
Corporation) that could cause actual events or results to differ materially from
those anticipated in the forward-looking information. Some of the risks and
other factors could cause results to differ materially from those expressed in
the forward-looking information include, but are not limited to: a change in
TSXV policies, general economic conditions in Canada, the United States and
globally, the risks associated with the oil and gas industry, commodity prices
and exchange rate changes. Readers are cautioned that this list of risk factors
should not be construed as exhaustive.


The forward-looking information contained in this news release is expressly
qualified by this cautionary statement. The Corporation does not undertake any
obligation to update or revise any forward-looking statements to conform such
information to actual results or to changes in our expectations except as
otherwise required by applicable securities legislation. Readers are cautioned
not to place undue reliance on forward-looking information.


The TSX Venture Exchange has in no way passed upon the merits of the proposed
transaction and has neither approved nor disapproved the contents of this press
release.

Life Sciences Institute Inc. (TSXV:LSN)
Historical Stock Chart
From May 2024 to Jun 2024

Life Sciences Institute Inc. (TSXV:LSN)
Historical Stock Chart
From Jun 2023 to Jun 2024